CalciMedica is trading at $0.93 (-7.22%) today as the stock pulls back from a recent rally fueled by FDA trial-alignment optimism.
- The decline follows a significant two-session surge, including a 19.05% gain on July 31, suggesting the move is a fade from recent highs rather than a new company setback.
- No fresh company-specific announcements or overnight catalysts were identified to explain the downward move.
- With broader U.S. futures trading only modestly higher, the price action appears to be stock-specific profit-taking after the sharp run-up.